195 related articles for article (PubMed ID: 24854231)
21. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
[TBL] [Abstract][Full Text] [Related]
22. Induction Toripalimab and Chemotherapy for Organ Preservation in Locally Advanced Laryngeal and Hypopharyngeal Cancer: A Single-Arm Phase II Clinical Trial.
Ou X; Zhai R; Wei W; Chen J; Ou D; Liao T; Xu T; Zhu Y; Wang Y; Huang S; Shi R; Wu B; Chen T; Li Y; Yang Z; Zhou C; Liu Y; Jiang Z; Zeng M; Liu X; Ji D; Ying H; Zhang Z; Hu C; Lu X; Ji Q; He X; Wang Y
Clin Cancer Res; 2024 Jan; 30(2):344-355. PubMed ID: 37955629
[TBL] [Abstract][Full Text] [Related]
23. Could the Addition of Cetuximab to Conventional Radiation Therapy Improve Organ Preservation in Those Patients With Locally Advanced Larynx Cancer Who Respond to Induction Chemotherapy? An Organ Preservation Spanish Head and Neck Cancer Cooperative Group Phase 2 Study.
Mesía R; Garcia-Saenz JA; Lozano A; Pastor M; Grau JJ; Martínez-Trufero J; Lambeaz J; Martínez-Galán J; Mel JR; González B; Vázquez S; Mañós M; Taberna M; Cirauqui B; Del Barco E; Casado E; Rubió-Casadevall J; Rodríguez-Jaráiz A; Cruz JJ;
Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):473-480. PubMed ID: 28011050
[TBL] [Abstract][Full Text] [Related]
24. [Prognostic factors affecting results of comprehensive treatment of hypopharyngeal carcinoma].
Xu W; Lyu Z; Yang Z; Zou J; Cao H
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Jul; 49(7):533-8. PubMed ID: 25257265
[TBL] [Abstract][Full Text] [Related]
25. Neoadjuvant treatment combined with planned surgery in laryngeal function preservation for locally advanced pyriform sinus carcinoma.
Yu Y; Wang X; Xu Z; Fan C; Tu G
J Craniofac Surg; 2014 Nov; 25(6):1975-9. PubMed ID: 25377955
[TBL] [Abstract][Full Text] [Related]
26. Induction chemotherapy (IC) followed by radiotherapy (RT) versus cetuximab plus IC and RT in advanced laryngeal/hypopharyngeal cancer resectable only by total laryngectomy-final results of the larynx organ preservation trial DeLOS-II.
Dietz A; Wichmann G; Kuhnt T; Pfreundner L; Hagen R; Scheich M; Kölbl O; Hautmann MG; Strutz J; Schreiber F; Bockmühl U; Schilling V; Feyer P; de Wit M; Maschmeyer G; Jungehülsing M; Schroeder U; Wollenberg B; Sittel C; Münter M; Lenarz T; Klussmann JP; Guntinas-Lichius O; Rudack C; Eich HT; Foerg T; Preyer S; Westhofen M; Welkoborsky HJ; Esser D; Thurnher D; Remmert S; Sudhoff H; Görner M; Bünzel J; Budach V; Held S; Knödler M; Lordick F; Wiegand S; Vogel K; Boehm A; Flentje M; Keilholz U
Ann Oncol; 2018 Oct; 29(10):2105-2114. PubMed ID: 30412221
[TBL] [Abstract][Full Text] [Related]
27. Management of contralateral N0 neck in pyriform sinus carcinoma.
Koo BS; Lim YC; Lee JS; Kim YH; Kim SH; Choi EC
Laryngoscope; 2006 Jul; 116(7):1268-72. PubMed ID: 16826073
[TBL] [Abstract][Full Text] [Related]
28. Prospective trial of chemotherapy-enhanced accelerated radiotherapy for larynx preservation in patients with intermediate-volume hypopharyngeal cancer.
Kawashima M; Hayashi R; Tahara M; Arahira S; Miyazaki M; Sakuraba M; Zenda S; Ogino T
Head Neck; 2012 Oct; 34(10):1363-8. PubMed ID: 22076936
[TBL] [Abstract][Full Text] [Related]
29. The effectiveness of chemoradiation therapy and salvage surgery for hypopharyngeal squamous cell carcinoma.
Suzuki K; Hayashi R; Ebihara M; Miyazaki M; Shinozaki T; Daiko H; Sakuraba M; Zenda S; Tahara M; Fujii S
Jpn J Clin Oncol; 2013 Dec; 43(12):1210-7. PubMed ID: 24031082
[TBL] [Abstract][Full Text] [Related]
30. Elective neck dissection for no neck during salvage total laryngectomy: findings, complications, and oncological outcome.
Basheeth N; O'Leary G; Sheahan P
JAMA Otolaryngol Head Neck Surg; 2013 Aug; 139(8):790-6. PubMed ID: 23949354
[TBL] [Abstract][Full Text] [Related]
31. Larynx preservation surgery in pyriform sinus cancer.
Yoo SJ; Lee SH; Koh KS; Kim SY
Int Surg; 2000; 85(2):93-8. PubMed ID: 11071322
[TBL] [Abstract][Full Text] [Related]
32. Induction chemotherapy in head and neck squamous cell carcinoma of the paranasal sinus and nasal cavity: a role in organ preservation.
Ock CY; Keam B; Kim TM; Han DH; Won TB; Lee SH; Hah JH; Kwon TK; Kim DW; Kim DY; Rhee CS; Wu HG; Sung MW; Heo DS
Korean J Intern Med; 2016 May; 31(3):570-8. PubMed ID: 26976150
[TBL] [Abstract][Full Text] [Related]
33. [Comparative analysis of clinical efficacies between induction chemotherapy and surgery combined with radiotherapy or concurrent chemoradiotherapy in advanced hypopharyngeal carcinoma].
Li ZD; Lu T
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Dec; 53(12):918-924. PubMed ID: 30585004
[No Abstract] [Full Text] [Related]
34. Larynx preservation with combined chemotherapy and radiation therapy in advanced but resectable head and neck cancer.
Pfister DG; Strong E; Harrison L; Haines IE; Pfister DA; Sessions R; Spiro R; Shah J; Gerold F; McLure T
J Clin Oncol; 1991 May; 9(5):850-9. PubMed ID: 2016629
[TBL] [Abstract][Full Text] [Related]
35. Retrospective analysis of the clinical efficacy of definitive chemoradiotherapy for patients with hypopharyngeal cancer.
Takehana K; Kodaira T; Tachibana H; Kimura K; Shimizu A; Makita C; Tomita N; Nishikawa D; Suzuki H; Hirakawa H; Hanai N; Hasegawa Y
Jpn J Clin Oncol; 2016 Apr; 46(4):344-9. PubMed ID: 26826721
[TBL] [Abstract][Full Text] [Related]
36. Early stage squamous cell carcinoma of the pyriform sinus: a review of treatment options.
Krstevska V
Indian J Cancer; 2012; 49(2):236-44. PubMed ID: 23107977
[TBL] [Abstract][Full Text] [Related]
37. Phase II organ-preservation trial: Concurrent cisplatin and radiotherapy for advanced laryngeal cancer after response to docetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapy.
Popovtzer A; Burnstein H; Stemmer S; Limon D; Hili O; Bachar G; Sopov V; Feinmesser R; Groshar D; Shvero J
Head Neck; 2017 Feb; 39(2):227-233. PubMed ID: 27556178
[TBL] [Abstract][Full Text] [Related]
38. Laryngeal preservation for advanced laryngeal and hypopharyngeal cancers.
Clayman GL; Weber RS; Guillamondegui O; Byers RM; Wolf PF; Frankenthaler RA; Morrison WH; Garden AS; Hong WK; Goepfert H
Arch Otolaryngol Head Neck Surg; 1995 Feb; 121(2):219-23. PubMed ID: 7840931
[TBL] [Abstract][Full Text] [Related]
39. Oncologic Outcomes After Salvage Laryngectomy for Squamous Cell Carcinoma of the Larynx and Hypopharynx: A Multicenter Retrospective Cohort Study.
Meulemans J; Debacker J; Demarsin H; Vanclooster C; Neyt P; Mennes T; Vauterin T; Huvenne W; Laenen A; Delaere P; Vander Poorten V
Ann Surg Oncol; 2021 Mar; 28(3):1751-1761. PubMed ID: 32860174
[TBL] [Abstract][Full Text] [Related]
40. Which Larynx-Preservation Strategy Would Be Best for a Patient With Resectable, Locally Advanced, Hypopharynx Squamous Cell Carcinoma?
Sobrevilla-Moreno N; Altamirano-Garcia JI; Granados-Garcia M; Garcilazo-Reyes A; Herrera-Martinez M; Alvarez-Avitia MA
Oncology (Williston Park); 2020 Jun; 34(6):211-215. PubMed ID: 32609868
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
